Causality and chance in the development of cancer

New England Journal of Medicine

Volumn 373, Issue 1, 2015, Pages 84-88

  Luzzatto, Lucio ^a   Pandolfi, Pier Paolo ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER RISK; CARCINOGENESIS; CHEMICAL CARCINOGENESIS; DNA REPAIR; ENVIRONMENTAL FACTOR; EPIGENETICS; FRAMESHIFT MUTATION; GENE FUNCTION; GENETIC ASSOCIATION; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; LIFESTYLE; LUNG CANCER; MALIGNANT NEOPLASTIC DISEASE; OSTEOSARCOMA; PRIORITY JOURNAL; SKIN CANCER; SOMATIC MUTATION; TUMOR MICROENVIRONMENT; CELL DIVISION; CELL TRANSFORMATION; EPIDEMIOLOGY; GENETICS; MUTATION; NEOPLASMS; PHYSIOLOGY; RISK; STEM CELL;

CARCINOGENESIS; CAUSALITY; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; GENE-ENVIRONMENT INTERACTION; HUMANS; MUTATION; NEOPLASMS; RISK; STEM CELLS;

EID: 84936166646     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMsb1502456     Document Type: Article

References (43)

1. Armitage P. Multistage models of carcinogenesis. Environ Health Perspect 1985; 63: 195-201.
2. Luzzatto L. Somatic mutations in cancer development. Environ Health 2011; 10: Suppl 1: S12.
3. Tomasetti C, Vogelstein B. Cancer etiology: variation in cancer risk among tissues can be explained by the number of stem cell divisions. Science 2015; 347: 78-81.
4. Weinberg RA. The biology of cancer. New York: Garland, 2007.
5. Cairns J. Mutation selection and the natural history of cancer. Nature 1975; 255: 197-200.
6. Armitage P, Doll R. The age distribution of cancer and a multi-stage theory of carcinogenesis. Br J Cancer 1954; 8: 1-12.
7. Knudson AG Jr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A 1971; 68: 820-3.
8. Tomasetti C, Marchionni L, Nowak MA, Parmigiani G, Vogelstein B. Only three driver gene mutations are required for the development of lung and colorectal cancers. Proc Natl Acad Sci U S A 2015; 112: 118-23.
9. Stratton MR. Exploring the genomes of cancer cells: progress and promise. Science 2011; 331: 1553-8.
10. Serero A, Jubin C, Loeillet S, Legoix-Né P, Nicolas AG. Mutational landscape of yeast mutator strains. Proc Natl Acad Sci U S A 2014; 111: 1897-902.
11. Araten DJ, Golde DW, Zhang RH, et al. A quantitative measurement of the human somatic mutation rate. Cancer Res 2005; 65: 8111-7.
12. Bebenek K, Pedersen LC, Kunkel TA. Replication infidelity via a mismatch with Watson-Crick geometry. Proc Natl Acad Sci U S A 2011; 108: 1862-7.
13. Dai C, Celestino JC, Okada Y, Louis DN, Fuller GN, Holland EC. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo. Genes Dev 2001; 15: 1913-25.
14. Lindberg N, Jiang Y, Xie Y, et al. Oncogenic signaling is dominant to cell of origin and dictates astrocytic or oligodendroglial tumor development from oligodendrocyte precursor cells. J Neurosci 2014; 34: 14644-51.
15. Tetteh PW, Farin HF, Clevers H. Plasticity within stem cell hierarchies in mammalian epithelia. Trends Cell Biol 2015; 25: 100-8.
16. Zhang XB, Felton JS, Tucker JD, Urlando C, Heddle JA. Intestinal mutagenicity of two carcinogenic food mutagens in transgenic mice: 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine and amino(alpha)carboline. Carcinogenesis 1996; 17: 2259-65.
17. Schwabe RF, Jobin C. The microbiome and cancer. Nat Rev Cancer 2013; 13: 800-12.
18. Buescher ES, Alling DW, Gallin JI. Use of an X-linked human neutrophil marker to estimate timing of lyonization and size of the dividing stem cell pool. J Clin Invest 1985; 76: 1581-4.
19. Tomasetti C, Vogelstein B. Cancer risk: Role of environment - response. Science 2015; 347: 729-31.
20. Albertini RJ, Nicklas JA, O'Neill JP, Robison SH. In vivo somatic mutations in humans: Measurement and analysis. Annu Rev Genet 1990; 24: 305-26.
21. Rondelli T, Berardi M, Peruzzi B, et al. The frequency of granulocytes with spontaneous somatic mutations: A wide distribution in a normal human population. PLoS One 2013; 8(1): E54046.
22. Wogan GN, Hecht SS, Felton JS, Conney AH, Loeb LA. Environmental and chemical carcinogenesis. Semin Cancer Biol 2004; 14: 473-86.
23. Peruzzi B, Araten DJ, Notaro R, Luzzatto L. The use of PIG-A as a sentinel gene for the study of the somatic mutation rate and of mutagenic agents in vivo. Mutat Res 2010; 705: 3-10.
24. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature 2008; 454: 436-44.
25. Hursting SD, Smith SM, Lashinger LM, Harvey AE, Perkins SN. Calories and carcinogenesis: lessons learned from 30 years of calorie restriction research. Carcinogenesis 2010; 31: 83-9.
26. Hecht SS. Lung carcinogenesis by tobacco smoke. Int J Cancer 2012; 131: 2724-32.
27. Miller YE, Blatchford P, Hyun DS, et al. Bronchial epithelial Ki-67 index is related to histology, smoking, and gender, but not lung cancer or chronic obstructive pulmonary disease. Cancer Epidemiol Biomarkers Prev 2007; 16: 2425-31.
28. Shlomai A, de Jong YP, Rice CM. Virus associated malignancies: The role of viral hepatitis in hepatocellular carcinoma. Semin Cancer Biol 2014; 26: 78-88.
29. Rivière L, Ducroux A, Buendia MA. The oncogenic role of hepatitis B virus. Recent Results Cancer Res 2014; 193: 59-74.
30. Phelps RA, Broadbent TJ, Stafforini DM, Jones DA. New perspectives on APC control of cell fate and proliferation in colorectal cancer. Cell Cycle 2009; 8: 2549-56.
31. Kottemann MC, Smogorzewska A. Fanconi anaemia and the repair of Watson and Crick DNA crosslinks. Nature 2013; 493: 356-63.
32. Fotouhi A, Hagos WW, Ilic M, et al. Analysis of mutant frequencies and mutation spectra in hMTH1 knockdown TK6 cells exposed to UV radiation. Mutat Res 2013; 751-752: 8-14.
33. Larsen MJ, Thomassen M, Gerdes AM, Kruse TA. Hereditary breast cancer: clinical, pathological and molecular characteristics. Breast Cancer (Auckl) 2014; 8: 145-55.
34. Yager JD, Davidson NE. Estrogen carcinogenesis in breast cancer. N Engl J Med 2006; 354: 270-82.
35. Santen R, Cavalieri E, Rogan E, et al. Estrogen mediation of breast tumor formation involves estrogen receptor-dependent, as well as independent, genotoxic effects. Ann N Y Acad Sci 2009; 1155: 132-40.
36. Feinberg AP, Vogelstein B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 1983; 301: 89-92.
37. Timp W, Feinberg AP. Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host. Nat Rev Cancer 2013; 13: 497-510.
38. Kulis M, Esteller M. DNA methylation and cancer. Adv Genet 2010; 70: 27-56.
39. Feinberg AP. Epigenetic stochasticity, nuclear structure and cancer: The implications for medicine. J Intern Med 2014; 276: 5-11.
40. Esteller M. Epigenetics provides a new generation of oncogenes and tumour-suppressor genes. Br J Cancer 2006; 94: 179- 83.
41. Steliga MA, Dresler C. Clinical practice and the tobacco epidemic: Relevance of a global public health problem in the clinical setting. Expert Rev Anticancer Ther 2010; 10: 1513-5.
42. De la Chapelle A. Genetic predisposition to colorectal cancer. Nat Rev Cancer 2004; 4: 769-80.
43. Bodmer W, Tomlinson I. Rare genetic variants and the risk of cancer. Curr Opin Genet Dev 2010; 20: 262-7.